Autopsy report · NCT04658251

Study of New Mutations in Cone Disorders

“End of COVID”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 months before it started.
• Ran for about 3 years 1 month before it stopped.
• 7 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

University Hospital, Lille

Sponsor type

University, hospital or other

Conditions

Retinal Dystrophy, Cone-Rod; Cone Dystrophy; Cone Rod Dystrophy; Macular Degeneration

Interventions

Blood and/or skin biopsy

Participants

7

Sites

1

Countries

France

Trials that died the same way

• Retrospective Study of COVID-19 Vaccines in Patients Undergoing Immunotherapy for Cancer.
  “end of the COVID outbreak” (88% match in meaning)
• LUMIER² Study : LUpus Molecular Immunomonitoring to Evaluate the Risk of Relapse
  “COVID situation” (77% match in meaning)
• Efficacy of a High-intensity Physical Activity Program on Renal Function in High Risk Patients With Type 2 Diabetes
  “COVID period” (73% match in meaning)
• Vitamin C to Reduce Vasopressor Dose in Septic Shock
  “COVID 19” (72% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.